Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

New Diet Advice for Adults with Epilepsy; Stomach Tissue from Stem Cells

October 30, 2014 8:42 am | Videos | Comments

According to researchers in Maryland, adults with epilepsy should consider a low-carb, high-fat diet. Also, doctors have created stomach tissue with stem cells.               

TOPICS:

PBOA Elects Chairman

October 30, 2014 8:33 am | News | Comments

The Pharma & Biopharma Outsourcing Association (PBOA), a new non-profit trade association devoted to advancing the interests of CMOs, CDMOs and other service providers, has elected Peter Bigelow to serve as Chairman of the Board of Trustees.

TOPICS:

Study: Young People More Likely to Survive Ebola

October 30, 2014 8:18 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

Who survives Ebola and why? Health workers treating patients in Sierra Leone, including some who died doing that work, have published the most detailed report yet on medical aspects of the epidemic. The research suggests young people are less likely to perish, fever is the most common symptom when victims first seek care, and early help is crucial.

TOPICS:
Advertisement

Showdown Imminent Over Nurse's Quarantine in Maine

October 30, 2014 8:12 am | by ROBERT F. BUKATY, Associated Press | News | Comments

State police plan to monitor the movements and interactions of a nurse who vowed to defy the state's quarantine for health care workers who treat Ebola patients, but troopers cannot take her into custody without a judge's permission.    

TOPICS:

FDA Approves Once-Daily XIGDUO™ XR Tablets for Adults with Type 2 Diabetes

October 30, 2014 8:04 am | News | Comments

AstraZeneca today announced that the FDA has approved once-daily XIGDUO™ XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes.               

TOPICS:

FDA Grants Accelerated Approval to Pfizer’s TRUMENBA®

October 29, 2014 3:22 pm | News | Comments

Pfizer announced that the FDA has granted accelerated approval of TRUMENBA ® (meningococcal group B vaccine) for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.

TOPICS:

Defense Secretary Hagel Approves 21-Day Ebola Quarantine for Troops

October 29, 2014 2:35 pm | by ROBERT BURNS, AP National Security Writer | News | Comments

All American troops returning from Ebola response missions in West Africa will be placed in supervised isolation for 21 days, Defense Secretary Chuck Hagel said Wednesday. He called it a "safety valve" sought by military members' families.  

TOPICS:

Novo Nordisk Now Hiring for New Manufacturing Facility in New Hampshire

October 29, 2014 2:20 pm | News | Comments

Novo Nordisk has announced plans to hire up to 90 people at its newly-acquired manufacturing plant in West Lebanon, NH. The facility was formerly owned by Olympus Biotech.             

TOPICS:
Advertisement

US Health Care Unprepared for Ebola

October 29, 2014 2:00 pm | by JEFF DONN, Associated Press; GARANCE BURKE, Associated Press | News | Comments

The U.S. health care apparatus is so unprepared and short on resources to deal with the deadly Ebola virus that even small clusters of cases could overwhelm parts of the system, according to an Associated Press review of readiness at hospitals and other components of the emergency medical network.

TOPICS:

Instantaneous Microbial Detection for Pharmaceutical Water Monitoring

October 29, 2014 11:34 am | Product Releases | Comments

The IMD-W™ rapid microbial detection system is designed for applications where the instrument can be used immediately to manage and mitigate risks, increase process understanding, save energy through better use of heat sanitization cycles, and drive labor efficiencies.

TOPICS:

EMA Advises on Development Plan for GSK Ebola Vaccine

October 29, 2014 11:15 am | News | Comments

The European Medicines Agency (EMA) has given scientific advice to GSK on its development plan for an Ebola vaccine. This is the first time in the current Ebola outbreak that EMA has given ‘rapid scientific advice’ using an accelerated procedure.

TOPICS:

GlobalData Analyst: Lack of Suitable Resources Limiting Ebola Diagnoses in West Africa

October 29, 2014 10:57 am | News | Comments

Poor logistics and low trained staff numbers are two of the greatest limitations to providing a sufficient molecular diagnostic capacity for Ebola in West Africa, where only 56% of cases are described as confirmed and the remaining cases are probable or suspected, according to an analyst with research and consulting firm GlobalData.

TOPICS:

Where's the Czar? Ebola Raises Management Questions

October 29, 2014 9:15 am | by JIM KUHNHENN, Associated Press | News | Comments

President Barack Obama's commander in the fight against Ebola was expected to operate below the public radar. But did that mean invisible? Ron Klain has barely been seen, and a week before midterm elections, Obama is pressing to dispel criticism that the government can't manage the Ebola crisis.

TOPICS:

Study: Chronic Fatigue Sufferers Have Brain Abnormality

October 29, 2014 9:08 am | Videos | Comments

Stanford researchers say that people with chronic fatigue syndrome have less white matter in their brains. Also, a new risk for prostate cancer patients.                

TOPICS:

The Flexible Filling Line: The Crossover Vehicle for Aseptic Manufacturing

October 29, 2014 8:59 am | by Paul Valerio, Director, Technology at IPS - Integrated Project Services | Blogs | Comments

People want it all, don’t they?  The type of cars many drive is one indicator.  Crossover vehicles have become a very popular vehicle segment.  They offer: practicality while still maintaining a cool factor; spaciousness with decent fuel efficiency; and car-like handling with the safety of all wheel drive for slippery conditions.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading